Author: therawinformant

Why you should buy ANZ and these ASX dividend shares for income
Fortunately for income investors in this low interest rate environment, there are a good number of shares on the ASX paying shareholders generous dividends.

Three which I think are quality options right now are listed below. Here’s why I would buy them:

Australia and New Zealand Banking GrpLtd (ASX: ANZ)

I think ANZ could be a good option for income investors. I believe the selloff of its shares has been overdone and has left them trading at an attractive price of just 13x estimated FY 2021 earnings and 0.9x FY 2021 book value. And while dividend cuts are inevitable, I’m expecting the banking giant to still pay one which provides a very generous yield next year. I’m forecasting a partially franked dividend of $1.05 per share in FY 2021. Based on the current ANZ share price, this will provide investors with a very generous forward 5.7% yield.

BHP Group Ltd (ASX: BHP)

Another dividend share to consider buying is BHP. I believe the Big Australian is well-positioned to generate strong free cash flows in FY 2020 and FY 2021 thanks to its low cost operations and favourable commodity prices. This is particularly the case for its iron ore operations, which are benefiting from spot prices of ~US$110 a tonne. This compares to its full year cost guidance of just US$13-14 per tonne for the Western Australia Iron Ore operation. Based on the latest BHP share price, I estimate that its shares offer investors a forward fully franked ~4.9% dividend yield.

Woolworths Limited (ASX: WOW)

A final ASX dividend share to consider buying is Woolworths. I think the conglomerate would be a good option for income investors due to its quality brands, their defensive qualities, and their positive long term outlooks. Combined with its supply chain improvement plans, I believe the company is well-positioned to continue growing its earnings and dividend at a solid rate over the next decade. Based on the current Woolworths share price, I estimate that its shares provide investors with a fully franked 3% FY 2021 dividend yield.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of June 30th

More reading
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Woolworths Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Why you should buy ANZ and these ASX dividend shares for income appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3jozqhV
20 July 2020
Trump vows to sign health care, immigration plans soon

In a new interview on Fox News, President Trump vows to approve new health care and immigration plans within ‘the next four weeks.’ Yahoo Finance’s Rick Newman and Akiko Fujita discuss.

from Yahoo Finance https://ift.tt/39m7WFe

20 July 2020
5 things to watch on the ASX 200 on Tuesday
On Monday the S&P/ASX 200 Index (ASX: XJO) was out of form and started the week on a disappointing note. The benchmark index fell 0.5% to 6,001.6 points.

Will the market be able to bounce back from this on Tuesday? Here are five things to watch:

ASX 200 expected to rebound.

It looks set to be a positive day of trade for the ASX 200 index on Tuesday. According to the latest SPI futures, the benchmark index is expected to open the day 45 points or 0.75% higher at the open. This follows a positive start to the week on Wall Street which saw the Dow Jones edge higher, the S&P 500 rise 0.85%, and the Nasdaq jumped 2.5% higher. The S&P 500’s gain means it is now in positive territory for 2020.

Tech shares on watch.

Tech shares including Altium Limited (ASX: ALU) and Appen Ltd (ASX: APX) could be on the rise today after an incredibly positive night of trade for their U.S. counterparts. The tech-focused Nasdaq index jumped 2.5% overnight thanks to strong gains by the likes of Amazon, Apple, Microsoft, and Google parent, Alphabet. Amazon was the star of the show with a gain of almost 8%.

Oil prices edge lower.

It could be a positive day for energy producers such as Oil Search Limited (ASX: OSH) and Santos Ltd (ASX: STO) on Tuesday after oil prices pushed higher. According to Bloomberg, the WTI crude oil price rose 0.3% to US$40.71 a barrel and the Brent crude oil price climbed 0.2% to US$43.22 a barrel. Coronavirus vaccine hopes supported oil prices.

Gold price rises.

Gold miners including Evolution Mining Ltd (ASX: EVN) and Northern Star Resources Ltd (ASX: NST) could be on the rise again on Tuesday after the gold price strengthened further. According to CNBC, the spot gold price rose 0.45% to US$1,818.5 an ounce. Overnight the price of the precious metal hit its highest level since September 2011.

Commonwealth Bank given sell rating.

Analysts at Goldman Sachs believe the Commonwealth Bank of Australia (ASX: CBA) share price could be going lower from here. Ahead of its full year results release next month, the broker has retained its sell rating and $65.00 price target on the banking giant’s shares. This price target implies potential downside of over 10%.

5 stocks under $5

We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

See the 5 stocks

*Extreme Opportunities returns as of June 5th 2020

More reading
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Altium. The Motley Fool Australia owns shares of Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post 5 things to watch on the ASX 200 on Tuesday appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/30tLaqR
20 July 2020
Suspect In Slaying Of Federal Judge’s Son Was Columbia MBA

Roy Den Hollander was found dead two hours from the site of the New Jersey attackThe post Suspect In Slaying Of Federal Judge's Son Was Columbia MBA appeared first on Poets&Quants.

from Yahoo Finance https://ift.tt/2E3jGkk

20 July 2020
IBM Revenue Beats Estimates on Boost From Cloud Demand

(Bloomberg) — International Business Machines Corp. beat analysts’ estimates for revenue in the second quarter, with cloud sales helping offset coronavirus-fueled declines in its consulting services business. The shares gained in late trading.The Armonk, New York-based company reported total cloud revenue increased 30% to $6.3 billion in the second quarter. That helped offset revenue declines in the tech support units Global Business Services and Global Technology Services, which account for about 56% of IBM’s total revenue. Overall, sales fell 5.4% to $18.1 billion, beating the $17.62 billion analysts had expected, according to data compiled by Bloomberg.Covid-19 has hit IBM’s services business hard since many of its clients have delayed purchases of information technology or software upgrades to focus on short-term stability and cash preservation to survive the pandemic. Other software makers have reported a similar dip in sales. But Chief Executive Officer Arvind Krishna said clients are seeing value in IBM’s hybrid cloud platform “at a time of unprecedented business disruption.”IBM shares rose about 6% in extended trading after closing at $126.37. They had declined 5.7% so far this year. Earnings excluding some costs fell 31%, to $2.18 a share, coming in above the average analyst estimate of $2.12.Krishna is steering the company through a global crisis while also spearheading IBM’s third major transformation in its 109-year history. IBM is hanging its future on cloud computing, aiming to become the leader in hybrid-cloud software and services, which allow clients to store data in private servers and in multiple public clouds, including those run by rivals Amazon.com Inc. and Microsoft Corp. In 2018, IBM spent $34 billion to buy open source software provider Red Hat to aid that transition.IBM reported Red Hat contributed close to $1.1 billion in the quarter, after a financial adjustment related to the acquisition.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

from Yahoo Finance https://ift.tt/2E3mCgR

20 July 2020
U.S. congressional body questions $700 mln loan to YRC Worldwide

from Yahoo Finance https://ift.tt/3eTSFwB

20 July 2020
IBM earnings beat estimates on cloud strength

International Business Machines Corp posted quarterly revenue and profit above analysts' estimates on Monday, riding on the strength of its high-margin cloud computing business. IBM has jettisoned some of its legacy business to focus on cloud computing, an area that has seen a lot of action in recent years as companies ramp up their digital shift to control costs and boost efficiency. Revenue from the cloud business, previously headed by IBM's new boss Arvind Krishna, rose 30% to $6.3 billion in the second quarter.

from Yahoo Finance https://ift.tt/3jscBKu

20 July 2020
Why earnings season is ‘going to be a dumpster fire’: Strategist

Wells Fargo Asset Management Multi-Asset Strategist Brian Jacobsen joins Yahoo Finance’s Akiko Fujita to discuss what to expect from upcoming earnings.

from Yahoo Finance https://ift.tt/3fN1LMM

20 July 2020
AstraZeneca Drops 3.5% Even As Covid-19 Vaccine Candidate Shows Promise in Trials

Shares in AstraZeneca (AZN) dropped 3.5% even after early-stage human trial data from its Covid-19 vaccine candidate showed “robust” immune responses.The stock declined to $58.96 in afternoon market trading. Interim data results from the ongoing Phase I/II trial of the potential coronavirus vaccine, also known as AZD1222, which AstraZeneca is developing with Oxford University, showed “strong” antibody and immune T-cell responses.“While there is more work to be done, today’s data increases our confidence that the vaccine will work and allows us to continue our plans to manufacture the vaccine at scale for broad and equitable access around the world,” said Mene Pangalos, Executive VP of BioPharmaceuticals R&D.The results demonstrated that a single dose of AZD1222 resulted in a four-fold increase in antibodies to the SARS-CoV-2 virus spike protein in 95% of participants one month after injection. In all participants, a T-cell response was induced, peaking by day 14, and maintained two months after injection.Neutralising activity against SARS-CoV-2 was seen in 91% of participants one month after vaccination and in 100% of participants who received a second dose. The levels of neutralising antibodies seen in participants receiving either one or two doses were in a similar range to those seen in convalescent COVID-19 patients.Late-stage Phase II/III trials are currently underway in the U.K., Brazil and South Africa and are due to start in the U.S., AstraZeneca said.The British drugmaker has in recent weeks signed supply chain agreements for the capacity to produce 2 billion doses of its vaccine candidate, should it prove to be successful. It has inked supply deals with the U.S. and European Union countries.AZD1222 is one of several candidates supported by Operation Warp Speed (OWS), the U.S. government program to accelerate the development, manufacturing, and distribution of COVID-19 vaccines available for Americans by Jan. 2021.Shares have jumped 10% in the past five days in anticipation of the trial results and are now up more than 18% year-to-date. In light of the recent rally, the $61.67 average analyst price target puts the upside potential at a more modest 4.7% in the coming 12 months. (See AstraZeneca stock analysis on TipRanks)Overall, the stock scores a Strong Buy consensus from the analyst community based on 4 unanimous Buy ratings.Related News: Pfizer, BioNTech Ink UK Supply Deal For 30M Covid-19 Vaccine Doses Moderna Soars 16% As Covid-19 Vaccine Shows Strong Immune Response GSK Buys 10% Stake In Germany’s CureVac To Develop mRNA Vaccines More recent articles from Smarter Analyst: * Chevron To Buy Noble Energy For $5 Billion In All-Stock Deal * Philips Reports Q2 Earnings Beat, Sending Shares Higher * Disney Delays Launch Of Its Marvel TV Series Citing Covid-19 Pandemic * Ford, Mobileye Join Forces To Boost Camera-Detection Systems

from Yahoo Finance https://ift.tt/2CWwR5O

20 July 2020
Fortress Biotech, Inc.’s (NASDAQ:FBIO) Path To Profitability

Fortress Biotech, Inc.'s (NASDAQ:FBIO): Fortress Biotech, Inc. develops and commercializes pharmaceutical and…

from Yahoo Finance https://ift.tt/2OEDxsb

20 July 2020